HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 148 filers reported holding HERON THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,857 | -11.3% | 13,453 | -0.1% | 0.00% | – |
| Q2 2023 | $15,622 | -14.6% | 13,467 | +11.2% | 0.00% | – |
| Q1 2023 | $18,289 | -44.8% | 12,112 | -8.5% | 0.00% | – |
| Q4 2022 | $33,105 | -31.0% | 13,242 | +16.7% | 0.00% | – |
| Q3 2022 | $48,000 | +50.0% | 11,344 | -1.9% | 0.00% | – |
| Q2 2022 | $32,000 | -67.7% | 11,562 | -33.3% | 0.00% | – |
| Q1 2022 | $99,000 | -46.2% | 17,324 | -14.0% | 0.00% | – |
| Q4 2021 | $184,000 | +44.9% | 20,146 | +70.2% | 0.00% | – |
| Q3 2021 | $127,000 | -65.9% | 11,838 | -50.6% | 0.00% | -100.0% |
| Q2 2021 | $372,000 | -2.1% | 23,968 | +2.4% | 0.00% | 0.0% |
| Q1 2021 | $380,000 | -7.5% | 23,417 | +20.6% | 0.00% | -50.0% |
| Q4 2020 | $411,000 | +158.5% | 19,415 | +80.7% | 0.00% | +100.0% |
| Q3 2020 | $159,000 | -9.1% | 10,742 | -9.8% | 0.00% | 0.0% |
| Q2 2020 | $175,000 | -34.7% | 11,910 | +4.5% | 0.00% | 0.0% |
| Q4 2019 | $268,000 | +0.4% | 11,395 | +35.1% | 0.00% | -50.0% |
| Q3 2018 | $267,000 | -18.1% | 8,432 | +0.3% | 0.00% | 0.0% |
| Q2 2018 | $326,000 | – | 8,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |